IP Verse

Bulle Dr competitive analysis

Loading summary...

Explore patent oppositions filed by Bulle Dr against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 22, 2025
EP3565419	Crystallisable D-Allulose Syrups	ROQUETTE FRRES	Feb 7, 2025
EP2395968	Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient	BOEHRINGER INGELHEIM	Oct 15, 2024
EP3626270	New Use	NOVARTIS	Jul 10, 2024
EP3532481	Method For Producing Allulose Crystals	TATE & LYLE INGREDIENTS AMERICAS	Mar 14, 2024
EP3810201	Gip/Glp1 Agonist Compositions	ELI LILLY	Mar 7, 2024
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 8, 2023
EP3663375	Structural Adhesive Compositions	PPG INDUSTRIES OHIO	Oct 18, 2023
EP3067043	Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor	NOVARTIS	Aug 28, 2023
EP3261455	Allulose Syrups	TATE & LYLE INGREDIENTS AMERICAS	Oct 26, 2022

Explore the latest publications and patents granted to Bulle Dr, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Bulle Dr, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Bulle Dr with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BULLE DR	19	-	-	-
ALFRED E TIEFENBACHER	44	3	-	-
ASTELLAS PHARMA	-	33	-	1
NOVARTIS	6	422	-	21